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http://dx.doi.org/10.1016/j.gmbhs.2Abstract Urinary tract infection (UTI) is the most common serious bacterial infection found
in febrile infants and young children who present without an obvious source of infection. This
study aimed to determine the prevalence of UTIs among neonates in Benin City, Nigeria. Supra-
pubic urine aspirate or catheter urine specimens were obtained from 266 (85 male and 181 fe-
male) neonates with signs and symptoms of UTI. Significant microbial isolates were identified
in the urine specimens, and an antimicrobial susceptibility test was performed on bacterial iso-
lates using standard techniques. Male sex was a significant risk factor for acquiring UTI in the
neonates (odds ratioZ 4.336, 95% confidence intervalZ 1.546e12.112, pZ 0.0064). Klebsiel-
la species were the organisms most prevalent in causing UTIs (28.57%) within all age groups of
neonates. Candida albicans was recovered only from neonates within the first week of life.
Although bacterial isolates were more susceptible to nitrofurantoin, the susceptibility profiles
of bacterial isolates were generally poor. An overall UTI prevalence rate of 6.39% was observed
among neonates. Male infants had an approximately 2e12-fold increased risk of acquiring a
UTI, and Klebsiella species were the isolates most predominant in causing neonatal UTI. Ra-
tional use of antibiotics is advocated to stem the tide of antibacterial resistance.
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Bacterial infection of the urinary tract, whether hospital
acquired or community acquired, occurs in all age groups
in both sexes and usually requires urgent treatment.1
Urinary tract infection (UTI) is the most common of the
serious bacterial infections found in febrile infants and
young children who present without an obvious source of
infection.2 The symptoms and signs of UTI in infants are
nonspecific, with hyperbilirubinemia commonly being the
main clinical feature of presentation and, in some cases,
the only manifestation of UTI.3 Failure to diagnose UTI,
resulting in a delay in the implementation of an appro-
priate therapy, has been reported to result in renal
scarring, hypertension, and kidney failure among
infants.2,3 Unconjugated hyperbilirubinemia is associated
with a variety of physiological and pathological
conditions.4
The prevalence of UTI varies depending on age, birth
weight, and whether the neonates in question are pre-
term or full term. However, an overall prevalence of
0.1e38.0% has previously been reported.2 Gram-negative
bacteria are commonly implicated as the etiological
agents of UTI; however, the species involved have varied
from one study to another.2,4,5 Moreover, no studies have
looked at changes in etiological agents within the neo-
natal period. Studies from developing countries about the
prevalence of UTI in neonates are limited, and none have
previously been conducted by University of Benin Teach-
ing Hospital (UBTH), Benin City, Nigeria. Against this
background, this study aimed to determine the preva-
lence of UTI among neonates in Benin City, Nigeria. The
effect of sex on this prevalence was also determined, in
addition to changes in etiological agents within the neo-
natal period and the susceptibility patterns of bacterial
isolates.
Materials and methods
Study population
The present study was carried out from March 2007 to April
2011 at UBTH. A total of 266 neonates, 85 male and 181
female, aged 1e28 days, were enrolled in this study. All
neonates had the signs and symptoms of UTI. Informed
consent was obtained from the parents of each neonateTable 1 Effect of age and sex on prevalence of neonatal urina
Characteristics No. tested No. infected (%)
Sex
Male 85 11 (12.94)
Female 181 6 (3.31)
Age (d)
1e7 106 11 (10.38)
8e14 92 4 (4.35)
15e21 48 0 (0.0)
22e28 20 2 (10.0)
CI Z confidence interval; OR Z odds ratio.prior to specimen collection. The Ethical Committee of
UBTH approved the protocol for this study.
Collection and processing
Suprapubic urine aspirate or catheter urine specimens
were obtained from each neonate and were placed in a
universal container holding a few crystals of boric acid as a
preservative. A loopful (0.001 mL) of the urine specimens
was streaked onto blood agar and a cysteinee
lactoseeelectrolyte deficient medium (M6; Plasmatec
Laboratories, Bridport, Dorset, UK) and was incubated at
37C for 24 hours. The presence of any organism or growth
from suprapubic urine aspirate or >104 cfu/mL from a
catheter specimen was considered sufficient to indicate the
presence of UTI.
The urine specimens were centrifuged at 2000 g for 5
minutes. The supernatant was discarded, and a drop of the
deposit was examined microscopically at high magnification
for pus cells, red blood cells, epithelial cells, casts, crys-
tals, yeast-like organisms, and Trichomonas vaginalis. The
presence of pus cells (5 per high power field) was con-
sidered sufficient to indicate infection. UTI was diagnosed
if the bacterial or pus cell count or both were significant for
an individual. Emergent isolates were identified using
standard microbiological techniques.6 A disc susceptibility
test for bacterial isolates was performed using the BSAC
method described by Andrews.7
Statistical analysis
The data obtained were analyzed by c2 test and an odds
ratio analysis using the statistical software INSTAT (Graph-
Pad Software Inc., La Jolla, CA, USA).
Results
The prevalence of UTI among neonates was 6.39%, and male
sex was a significant risk factor for acquiring the infection
(male vs. female; 12.94% vs. 3.31%; odds ratioZ 4.336; 95%
confidence interval Z 1.546e12.112; p Z 0.0064). The
prevalence of UTI decreased among neonates aged 1e7
days and 15e21 days, and then began to rise again among
those aged 22e28 days. However, the prevalence of UTI in
relation to the age of the neonates was not statistically
significant (p Z 0.067) (Table 1).ry tract infection.
OR 95% CI p value
4.336 1.546e12.112 0.0064
0.231 0.082e0647
0.067
Table 2 Etiological agents of neonatal urinary tract infection in relation to age.
Organism No. (%) Total
1e7 d 8e14 d 15e21 d 22e28 d
Escherichia coli 0 (0.00) 1 (16.66) 0 (0.0) 1 (50.0) 2 (9.53)
Klebsiella spp. 3 (23.06) 2 (33.33) 0 (0.0) 1 (50.0) 6 (28.57)
Enterobacter spp. 1 (7.69) 0 (0.0) 0 (0.0) 0 (0.0) 1 (4.76)
Providencia spp. 1 (7.69) 0 (0.0) 0 (0.0) 0 (0.0) 1 (4.76)
Proteus mirabilis 3 (23.06) 1 (16.66) 0 (0.0) 0 (0.0) 4 (19.05)
Alcaligenes spp. 1 (7.69) 0 (0.0) 0 (0.0) 0 (0.0) 1 (4.76)
Staphylococcus aureus 2 (15.38) 2 (33.33) 0 (0.0) 0 (0.0) 4 (19.05)
Candida albicans 2 (15.38) 0 (0.0) 0 (0.0) 0 (0.0) 2 (9.52)
Total 13 (99.95) 6 (99.98) 0 (0.0) 2 (30.0) 21 (100)
120 R. Omoregie et al.Klebsiella species were the most prevalent organism
that caused UTI in neonates, with a prevalence of 28.57%.
This was followed by Proteus mirabilis and Staphylococcus
aureus with a prevalence of 19.05% each. In relation to
the age of neonates, more isolates were recovered with
the first 7 days of life, with Klebsiella species and P.
mirabilis being the most prevalent (23.08%). Within 8e14
days of life, Klebsiella species and S. aureus predomi-
nated, with a prevalence of 33.33%. No isolate was
recovered at 15e21 days old, whereas only Escherichia
coli and Klebsiella species were recovered within 22e28
days of neonatal life, with a prevalence of 50.0% each
(Table 2).
The susceptibility profile involving bacterial isolates
from neonates is generally poor. Depending on the isolates,
the susceptibility to any antibacterial agents may range
from 0% to 100%. With the exception of P. mirabilis and
S. aureus, the susceptibility of bacterial isolates to nitro-
furantoin was moderate to high. The only Providencia and
Alcaligenes recovered were susceptible only to nitro-
furantoin and cefuroxime, respectively (Table 3).Discussion
UTI is the most common serious bacterial infection found in
febrile infants and young children who present without an
obvious source of infection.2 The prevalence of UTI variesTable 3 Antibacterial susceptibility profiles of bacterial agents
Antibacterial agents (mg/disc) AMX
(30)
AUG
(30)
CAZ
(30)
CRO
(30)
G
(Organism
Escherichia coli (n Z 2) d d d d d
Klebsiella spp. (n Z 6) d d 3
(50%)
1
(16.67%) (
Enterobacter spp. (n Z 1) d d d d d
Providencia spp. (n Z 1) d d d d d
Proteus mirabilis (n Z 4) d d d 1 (25%) 1
Alcaligenes spp. (n Z 1) d d d d d
Staphylococcus aureus
(n Z 4)
1
(25%)
1
(25%)
d 1 (25%) 1
AMXZ amoxicillin; AUGZ amoxicillineclavulanate; CAZZ ceftazidi
GN Z gentamicin; NA Z nalidixic acid; NF Z nitrofurantoin; OFX Zwith age, birth weight, and whether the neonates are
preterm or full term.2 This study focused on determining
the prevalence of UTI among neonates. The effect of age on
the distribution of the microbial agents of UTI as well as on
the susceptibility profiles of bacterial isolates was also
determined.
A 6.39% prevalence of neonatal UTI was observed in this
study. This value is comparable with the 6.0% reported in a
previous study.3 However, it is lower than the prevalence
reported in other studies, 8.0e38.0%.2,4,5 In these studies
with higher prevalence of UTI, the neonates had jaundice or
a positive blood culture. In UBTH, the practice in treating
neonates with any sign of ailment is to perform a spectrum of
tests, including blood, urine, and cerebrospinal fluid cul-
tures, as well as blood tests for malarial parasites and bilir-
ubin levels (total and unconjugated). Although not part of
this study, hyperbilirubinemia is associated with UTI,3 and
may have been present in our patients.
The finding that male sex was a risk factor for UTI among
neonates agrees with previous reports.2,3,5 Also, being
older than 48 hours has been reported as a risk factor for
neonatal UTI.2 In this study, the prevalence of UTI was
highest within the first week of life (1e7 days). However,
the prevalence within the age group did not differ sig-
nificantly (p Z 0.067) when compared with other neonatal
age groups. The cause of this could not be determined.
Klebsiella species were the most prevalent organism
that caused neonatal UTI in this study. This agrees with theof neonatal urinary tract infection.
N
10)
NA (30) CIP (5) OFX (5) NF (300) CXM (30)
d 1 (50%) d 1 (50%) d
2
33.33%)
2
(33.33%)
2
(33.33%)
4 (66.67) 5 (83.33) 3 (50%)
d 1 (100%) 1 (100%) 1 (100%) d
d d d 1 (100%) d
(25%) 2 (50%) d d 1 (25%) d
d d d d 1 (100%)
(25%) 1 (25%) 1 (25%) 2 (50%) 1 (25%) d
me; CIPZ ciprofloxacin; CROZ ceftriaxone; CXMZ cefuroxime;
ofloxacin.
UTIs among neonates in Benin City, Nigeria 121study of Omar et al4 but differs from other studies.2,3 The
etiological agent of neonatal UTI differs based on geo-
graphical locations. Bilgen et al5 in Turkey have reported
Enterobacter aerogenes to be the most prevalent isolate
causing UTI. In relation to neonatal age, Candida albicans
was recovered only within the first week of life. The reason
for this, however, is not clear because infections with
Candida species are associated with immune deficiency and
antibiotic usage. Perhaps the neonates are immunodefi-
cient as a result of HIV infection or any other morbidity that
can result in immunosuppression. However, further inves-
tigations are required to verify this assumption.
Nitrofurantoin is generally the most active antibacterial
agent. However, it is contraindicated in neonates, in whom
it may result in hemolytic anemia. The susceptibility pat-
tern showed very poor to high susceptibility depending on
the organism and the antibacterial agents. This indicated
that the isolates may have been acquired from the hospital
environment, underscoring the need for a proper imple-
mentation of antibiotic policy and control measures against
hospital-acquired infections.
The present study reveals an overall prevalence of
6.39% for neonatal UTI. Male sex was a risk factor for
acquiring neonatal UTI, and Klebsiella species were the
predominant isolates implicated in causing UTIsirrespective of the age of the neonate. Measures to reduce
or eliminate neonatal UTI caused by resistant pathogens
are promoted.References
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